Phage therapy against Achromobacter xylosoxidans lung infection in a patient with cystic fibrosis: a case report

Respiratory infections can lead to serious complications in CF patients, especially when infected with antibiotic resistant bacteria. Alternative treatments for these infections are being sought out to help address this problem. We present a clinical case of a cystic fibrosis (CF) patient, with multi-drug resistant (MDR) Achromobacter xylosoxidans chronic lung infection who was successfully managed with bacteriophage therapy. (C) 2018 Published by Elsevier Masson SAS on behalf of Institut Pasteur.